FibroGen, Inc (FGEN) financial statements (2021 and earlier)

Company profile

Business Address 409 ILLINOIS STREET
SAN FRANCISCO, CA 94158
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments687534621736253181
Cash and cash equivalents67812689674174153
Short-term investments8407532627928
Receivables4215464121015
Inventory, net of allowances, customer advances and progress billings177    
Inventory177    
Prepaid expense86    
Other current assets22    
Other undisclosed current assets  5134
Total current assets:755702690749267201
Noncurrent Assets
Finance lease, right-of-use asset 40
Operating lease, right-of-use asset22
Property, plant and equipment3443127129124129
Long-term investments and receivables061561171132
Long-term investments061561171132
Restricted cash and investments     7
Other noncurrent assets393522
Other undisclosed noncurrent assets320456 
Total noncurrent assets:72155191150203270
TOTAL ASSETS:827857881899470471
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities25675695754
Accounts payable2569667
Accrued liabilities  66645148
Deferred revenue70
Debt1212    
Deferred revenue and credits8813
Contract with customer, liability14
Other undisclosed current liabilities12084    
Total current liabilities:16310389776567
Noncurrent Liabilities
Long-term debt and lease obligation2538    
Finance lease, liability2538
Liabilities, other than long-term debt17816414912411794
Deferred revenue and credits11611190
Deferred revenue13899
Contract with customer, liability136
Deferred rent credit  3
Other liabilities406410865
Other undisclosed noncurrent liabilities1918114115112112
Total noncurrent liabilities:222219263239229207
Total liabilities:385322352316294274
Stockholders' equity
Stockholders' equity attributable to parent422516509563156178
Common stock111111
Additional paid in capital1,4001,3011,2261,160626587
Accumulated other comprehensive loss(4)(1)(2)(2)(1)(2)
Accumulated deficit(974)(785)(716)(596)(470)(408)
Stockholders' equity attributable to noncontrolling interest191919191919
Total stockholders' equity:441535528582175197
TOTAL LIABILITIES AND EQUITY:827857881899470471

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Gross profit:176257213126180181
Operating expenses(368)(346)(300)(248)(233)(258)
Operating loss:(192)(89)(87)(123)(54)(78)
Interest and debt expense(2)(3)(11)(10)(11)(11)
Loss from continuing operations before equity method investments, income taxes:(194)(92)(98)(132)(64)(89)
Other undisclosed income from continuing operations before income taxes51612633
Loss from continuing operations before income taxes:(189)(77)(86)(126)(62)(86)
Income tax expense (benefit)(0)(0)(0)(0)0(0)
Net loss available to common stockholders, diluted:(189)(77)(86)(126)(62)(86)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(189)(77)(86)(126)(62)(86)
Other comprehensive income (loss)(4)11(1)11
Comprehensive loss, net of tax, attributable to parent:(193)(76)(86)(127)(61)(84)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: